Hepatocellular carcinoma in Stockholm, Sweden 2003–2018: a population-based cohort study

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Torner A, Stokkeland K, Svensson A, et al. The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence. Hepatology. 2017;65(3):885–892.
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Askling J, Ludvigsson JF, et al. Validity of administrative codes associated with cirrhosis in Sweden. Scand J Gastroenterol. 2020;55(10):1205–1210.
   PubMed Web of Science ®Google Scholar
• Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171.
   PubMed Web of Science ®Google Scholar
• Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–491.e1.
   PubMed Web of Science ®Google Scholar
• Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718–735.
   PubMed Web of Science ®Google Scholar
• Neovius K, Johansson K, Kark M, et al. Trends in self-reported BMI and prevalence of obesity 2002–10 in Stockholm county, Sweden. Eur J Public Health. 2013;23(2):312–315.
   PubMed Web of Science ®Google Scholar
• National Board of Health and Welfare's Cancer Register [Internet]; 2020 [cited 2021 Sept 15]. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/swedish-cancer-register/
   Google Scholar
• Edenvik P, Davidsdottir L, Oksanen A, et al. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? Liver Int. 2015;35(7):1862–1871.
   PubMed Web of Science ®Google Scholar
• Henriksson M, Bjornsson B, Sternby Eilard M, et al. Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish National Registry SweLiv. BJS Open. 2020;4(1):109–117.
   PubMed Web of Science ®Google Scholar
• Nilsson E, Anderson H, Sargenti K, et al. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study. Scand J Gastroenterol. 2019;54(8):1027–1032.
   PubMed Web of Science ®Google Scholar
• Davidsdottir L, Duberg AS, Torner A, et al. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country. Scand J Gastroenterol. 2010;45(7–8):944–952.
   PubMed Web of Science ®Google Scholar
• Strauss R, Torner A, Duberg AS, et al. Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden – a low endemic country. J Viral Hepat. 2008;15(7):531–537.
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Stål P, Wahlin S, et al. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis. Liver Int. 2019;39(6):1098–1108.
   PubMed Web of Science ®Google Scholar
• Simon TG, Roelstraete B, Sharma R, et al. Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study. Hepatology. 2021;74(5):2410–2423.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Karalli A, Teiler J, Haji M, et al. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting. Scand J Gastroenterol. 2019;54(7):905–912.
   PubMed Web of Science ®Google Scholar
• Center of Epidemiology and Community Medicine in Region Stockholm. Living conditions, living habits and health in Stockholm County; 2014 [cited 2021 Sept 15]. Available from: http://dok.slso.sll.se/CES/FHG/Jamlik_halsa/Rapporter/livsvillkor-levnadsvanor-halsa.2014_3.2014.pdf
   Google Scholar
• Douglas L, Szatkowski L. Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the mosaic classification in a large dataset of primary care records. BMC Public Health. 2013;13:546.
   PubMed Web of Science ®Google Scholar
• de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–e190.
   PubMed Web of Science ®Google Scholar
• Nordvik M, Axelsson M, Berglund T, et al. Estimation of the number of individuals living with hepatitis C-infection in Sweden: Monica K. Nordvik. Eur J Public Health. 2016;26(suppl_1). DOI: 10.1093/eurpub/ckw174.206
   Google Scholar
• Public health agency of Sweden. Overweight and obesity; 2018 [cited 2021 Sept 15]. Available from: https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/living-conditions-and-lifestyle/obesity/
   Google Scholar
• Alexander M, Loomis AK, van der Lei J, et al. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. BMC Med. 2019;17(1):95.
   PubMedGoogle Scholar
• Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20.
   PubMed Web of Science ®Google Scholar
• Trolldal L. CAN report; Alcohol consumption i Sweden 2016; 2017 [cited 2021 Sep 15]. Available from: http://www.can.se/contentassets/3ecc5b9f2dd849bd992e23094b5a8473/alkoholkonsumtionen-i-sverige-2016.pdf
   Google Scholar
• Singal AG, Mittal S, Yerokun OA, et al. Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. Am J Med. 2017;130(9):1099–1106.e1.
   PubMed Web of Science ®Google Scholar